Article
Prognostic implications of epidermal growth factor receptor and KRAS gene mutations and epidermal growth factor receptor gene copy numbers in patients with surgically resectable non-small cell lung cancer in Taiwan.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Aug 2010
Liu Hui-Ping, Isaac Wu Hong-Dar, Chang John Wen-Cheng, Wu Yi-Cheng, Yang Hsin-Yi, Chen Ya-Ting, Hsieh Wen-You, Chen Ying-Tsong, Chen Yi-Rong, Huang Shiu-Feng
Abstract excerpt
INTRODUCTION: The prognostic role of epidermal growth factor receptor (EGFR) mutations in patients with surgically resectable non-small cell lung cancer (NSCLC) without EGFR tyrosine kinase inhibitor treatment has not been well established, because the reports are still few. MATERIALS AND METHODS: We analyzed the survival data of 164 patients with surgically resectable (stages I to IIIA) NSCLC of two year groups...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.